Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
The most comprehensive method for keeping track of all your investments. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or
Pfizer Inc (PFE)
Pfizer Inc (PFE)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 212,263,536
  • Shares Outstanding, K 5,645,307
  • Annual Sales, $ 100,330 M
  • Annual Income, $ 31,372 M
  • 60-Month Beta 0.63
  • Price/Sales 2.13
  • Price/Cash Flow 4.93
  • Price/Book 2.10
Trade PFE with:

Options Overview Details

View History
  • Implied Volatility 24.97% ( +0.54%)
  • Historical Volatility 23.23%
  • IV Percentile 40%
  • IV Rank 32.75%
  • IV High 35.97% on 10/11/22
  • IV Low 19.61% on 05/02/23
  • Put/Call Vol Ratio 0.95
  • Today's Volume 110,630
  • Volume Avg (30-Day) 148,964
  • Put/Call OI Ratio 0.77
  • Today's Open Interest 1,656,005
  • Open Int (30-Day) 1,511,957

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 15 analysts offering recommendations.
Earnings Estimates - Current Qtr 06/30/23
See More
  • Average Estimate 0.64
  • Number of Estimates 7
  • High Estimate 0.77
  • Low Estimate 0.51
  • Prior Year 2.04
  • Growth Rate Est. (year over year) -68.63%

Price Performance

See More
Period Period Low Period High Performance
1-Month
36.17 +2.32%
on 05/18/23
40.14 -7.80%
on 05/24/23
-1.88 (-4.83%)
since 04/28/23
3-Month
36.17 +2.32%
on 05/18/23
42.22 -12.34%
on 04/05/23
-3.56 (-8.77%)
since 02/28/23
52-Week
36.17 +2.32%
on 05/18/23
54.93 -32.62%
on 12/14/22
-16.90 (-31.35%)
since 05/27/22

Most Recent Stories

More News
Pfizer's Heading for a Patent Cliff. Is the Stock Still a Buy?

Last year, Pfizer reported record revenue.

PFE : 37.01 (-1.57%)
The Top Healthcare Stocks to Buy With $100

There's plenty of upside in this multitrillion-dollar industry.

PFE : 37.01 (-1.57%)
CVS : 67.15 (-0.72%)
HIMS : 8.88 (-2.09%)
Investing $43 in This Stock per Week for 5 Years Could Give You $500 in Annual Dividend Income

The risk of a dividend cut is minimal, and the yield of this stock is favorable.

PFE : 37.01 (-1.57%)
MarketBeat Week in Review – 5/22 - 5/26

The debt ceiling standoff and inflation continue to fight for investors’ attention as we head into what is historically a quieter period for the markets

AI : 43.95 (+33.42%)
IONQ : 10.99 (+9.90%)
BLBD : 26.66 (+1.37%)
DKS : 127.40 (+1.59%)
PFE : 37.01 (-1.57%)
PANW : 212.48 (+0.37%)
NVDA : 401.11 (+2.99%)
ZM : 65.68 (-0.89%)
CSIQ : 43.40 (-0.37%)
BOOT : 69.55 (-1.36%)
RCL : 80.26 (+1.59%)
3 No-Brainer Stocks to Buy for Under $100 Right Now

These stocks might not remain under $100 for too much longer.

CRSP : 64.63 (-0.05%)
NVCR : 71.04 (-3.43%)
PFE : 37.01 (-1.57%)
The Global Metastatic Breast Cancer Treatment Market Expected To Reach $31 Billion By 2028

EQNX::TICKER_START (NASDAQ:ONCY),(TSX:ONC),(NYSE:PFE),(NASDAQ:OCEA),(NYSE:NVS),(NASDAQ:RLAY) EQNX::TICKER_END

ONCY : 1.7200 (-1.71%)
ONC.TO : 2.32 (-8.66%)
PFE : 37.01 (-1.57%)
OCEA : 4.97 (-3.87%)
NVS : 96.55 (-1.34%)
RLAY : 10.94 (-0.55%)
The Global Metastatic Breast Cancer Treatment Market Expected To Reach $31 Billion By 2028

/PRNewswire/ -- Metastatic breast cancer is the advanced stage of breast cancer, including cases wherein cancer has spread to the other parts of the body from...

ONC.TO : 2.32 (-8.66%)
ONCY : 1.7200 (-1.71%)
PFE : 37.01 (-1.57%)
OCEA : 4.97 (-3.87%)
NVS : 96.55 (-1.34%)
RLAY : 10.94 (-0.55%)
Why Pfizer Stock Slipped by 2% Today

The market wasn't impressed by the company's latest drug approval, plus an analyst cut her price target on the shares.

BNTX : 104.35 (-0.87%)
PFE : 37.01 (-1.57%)
Astellas Highlights Continued Delivery of Strong Cancer Portfolio and Pipeline at 2023 ASCO Annual Meeting

/PRNewswire/ -- Astellas Pharma Inc. (TSE: 4503, President and CEO: Naoki Okamura, "Astellas") will share new research from across its expanding portfolio of...

PFE : 37.01 (-1.57%)
Wall Street Expects These Stocks to Soar 175% and 545%. Should You Buy?

These companies haven't given up on the coronavirus vaccine market.

MRNA : 128.89 (+2.10%)
PFE : 37.01 (-1.57%)
NVAX : 7.43 (+3.05%)
OCGN : 0.4583 (-1.02%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 100% Sell with a Strongest short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Business Summary

Pfizer Inc. is a research-based, global biopharmaceutical company. The company boasts a sustainable pipeline with multiple late-stage programs that can drive growth. Pfizer markets a wide range of drugs and vaccines. Its business comprises six business units - Oncology, Inflammation & Immunology, Rare...

See More

Key Turning Points

3rd Resistance Point 37.71
2nd Resistance Point 37.54
1st Resistance Point 37.27
Last Price 37.01
1st Support Level 36.83
2nd Support Level 36.66
3rd Support Level 36.39

See More

52-Week High 54.93
Fibonacci 61.8% 47.76
Fibonacci 50% 45.55
Fibonacci 38.2% 43.34
Last Price 37.01
52-Week Low 36.17

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar